Among active 13F managers last quarter, 1 opened and 2 added, while none reduced or exited; the largest holder to move was Yiheng Capital Management, L.P. (new position). Over the last 180 days, 2 insiders bought and none sold, a net +$38K in open-market trades.
Funds lean in and no leg opposes.
12 tracked 13F filers disclose a position in TOUR as of the latest SEC 13F filings, a combined $5.8M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Morgan Stanley | 4.1M | $3.1M | ▼−17% Reduced · −821K sh | Q1 2026 | |
| 2 | Goldman Sachs Group Inc | 1.2M | $951K | ▼−3.1% Reduced · −40K sh | Q1 2026 | |
| 3 | UBS Group AG | 1.0M | $789K | ▼−53% Reduced · −1.1M sh | Q1 2026 | |
| 4 | Bank Of America Corp | 477K | $367K | —Held | Q1 2026 | |
| 5 | Renaissance Technologies LLC | 179K | $138K | ▲+6.3% Added · +11K sh | Q1 2026 | |
| 6 | Dimensional Fund Advisors LP | 145K | $112K | —Held | Q1 2026 | |
| 7 | Jane Street Group, LLC | 117K | $90K | ▲+131% Added · +66K sh | Q1 2026 | |
| 8 | XTX Topco Ltd | 60K | $46K | ▲+369% Added · +47K sh | Q1 2026 | |
| 9 | BNP Paribas Financial Markets | 47K | $36K | ▲+3.5% Added · +2K sh | Q1 2026 | |
| 10 | Yiheng Capital Management, L.P. | 31K | $152K | ▲New +31K sh | Q2 2026 | |
| 11 | Rhumbline Advisers | 16K | $12K | —Held | Q1 2026 | |
| 12 | Simplex Trading, LLC | 2K | $2K | ▲+20% Added · +378 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 1 fund opened a new position in TOUR and 2 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Noah Holdings Ltd-Spon AdsNOAH | 1 funds | $67.1M |
| Bilibili Inc-Sponsored ADRBILI | 1 funds | $25.4M |
| Jd.com Inc-ADRJD | 1 funds | $15.0M |
| H World Group Ltd-ADRHTHT | 1 funds | $13.5M |
| Hinge Health Inc-AHNGE | 1 funds | $13.0M |
| Silvaco Group IncSVCO | 1 funds | $12.5M |
| Atrenew IncRERE | 1 funds | $12.2M |
| Bill Holdings IncBILL | 1 funds | $8.1M |
| New Oriental Educatio-SP ADREDU | 1 funds | $7.5M |
| Viridian Therapeutics IncVRDN | 1 funds | $7.4M |
| Kymera Therapeutics IncKYMR | 1 funds | $7.3M |
| Tal Education Group- ADRTAL | 1 funds | $7.3M |
Ranked by how many of TOUR's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in TOUR.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Chen Anqiang | Financial Controller | Buy (P) | 3K | $2K |
| Mar 30, 2026 | Chen Anqiang | Financial Controller | Buy (P) | 1K | $780 |
| Mar 24, 2026 | Dunde Yu | Chief Executive Officer, Director | Buy (P) | 2K | $1K |
| Mar 23, 2026 | Chen Anqiang | Financial Controller | Buy (P) | 3K | $2K |
| Mar 23, 2026 | Dunde Yu | Chief Executive Officer, Director | Buy (P) | 27K | $20K |
| Mar 20, 2026 | Chen Anqiang | Financial Controller | Buy (P) | 17K | $12K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 5 | 3 | – |
Insiders Form 4 open-market | 2 | 0 | +$38K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
| Class | 13F holders | Value held |
|---|---|---|
| TOURthis pageSPONSORED ADS | 11 funds | $5.7M |
| 89977P205SPONSORED ADS | 1 funds | $152K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for TOUR
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TOUR/capital-change-brief"
Use Arkolith's capital_change_brief for TOUR. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TOUR. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.